A Diagnostic Study of the Advanced Endoscopy to Detect Early Esophageal Cancer
NCT ID: NCT02182804
Last Updated: 2020-08-28
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
44 participants
INTERVENTIONAL
2013-02-28
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Narrow Band Imaging (NBI) Against Lugol for Squamous Esophageal Cancer
NCT02002559
Value of Narrow Band Imaging (NBI) Endoscopy in the Early Diagnosis of Laryngeal Cancer and Precancerous Lesions
NCT02217358
Study of Narrow Band Imaging in the Characterization of Residual Neoplasia After Endoscopic Piecemeal Mucosal Resection
NCT02448693
CLE for Assessment of Neoplasia After Mucosal Ablation or Resection of Gastrointestinal Neoplasia
NCT01032044
a Prospective Study on the Efficacy of Magnifying Endoscopy With Narrow-band Imaging in Diagnosing Gastric Lesions
NCT01508520
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study
probe-based confocal laser endomicroscopy narrow band imaging with magnification
Olympus
narrow band imaging with magnification
Cellvizio
probe-based confocal laser endomicroscopy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Olympus
narrow band imaging with magnification
Cellvizio
probe-based confocal laser endomicroscopy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having histological-confirmed diagnosis of head and neck cancer
* Having no esophageal symptoms
Exclusion Criteria
* History of esophageal surgery
* Having esophageal stricture or obstruction
* Having esophageal varices
* Known case of esophageal cancer
* Uncorrectable coagulopathy and thrombocytopenia
* Pregnancy
* Thyrotoxicosis
* Creatinine clearance less than 30 ml/min
* Allergy to iodine or fluorescein.
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chulalongkorn University
OTHER
King Chulalongkorn Memorial Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rapat Pittayanon
Gastroenterologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rapat Pittayanon, M.D.
Role: PRINCIPAL_INVESTIGATOR
King Chulalongkorn Memorial Hospital
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RP008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.